All terms in BAO
| Label | Id | Description |
|---|---|---|
| cardiotonic drug | CHEBI_38147 | |
| EC 2.5.1.29 (geranylgeranyl diphosphate synthase) inhibitor | CHEBI_64411 | |
| biological pigment | CHEBI_26130 | |
| quantitative reverse transcription PCR | BAO_0002090 | [Quantitative reverse transcription PCR is a PCR technique used to determine the amount of cDNA in a sample. It is the most commonly used form of quantitative PCR (qPCR). This technique is also called real-time reverse transcription PCR.] |
| reverse transcription PCR | BAO_0002089 | [Reverse transcription polymerase chain reaction (RT-PCR) is a variant of PCR in which the RNA strand is first reverse transcribed into its DNA complement (complementary DNA, or cDNA) using the enzyme reverse transcriptase, and the resulting cDNA is amplified using traditional or real-time PCR.] |
| reference compound | BAO_0002092 | [The role of a small molecule to act as a standard in a particular assay type, e.g., 1,4-Dioxane (for NMR), Cediranib (for Kinomescan).] |
| carrier | BAO_0002093 | [Role of a protein in the transport of ions, small molecules, or macromolecules across a semi-permeable membrane, such as plasma membrane.] |
| biofilm formation | GO_0042710 | [A process in which planktonically growing microorganisms grow at a liquid-air interface or on a solid substrate under the flow of a liquid and produce extracellular polymers that facilitate matrix formation, resulting in a change in the organisms' growth rate and gene transcription.] |
| coupled enzyme | BAO_0002096 | [The role played by an enzyme in reporting the activity of a different enzyme by being able to use the substrate or product of the latter in its own reaction (either as a substrate or cofactor). E.g., luciferase acts as a coupled enzyme for cytochrome P450, as the luciferin generated (from modified luciferin) by the latter acts as its substrate.] |
| autophagosome | GO_0005776 | [A double-membrane-bounded compartment that engulfs endogenous cellular material as well as invading microorganisms to target them to the lytic vacuole/lysosome for degradation as part of macroautophagy.] |
| EC 3.4.22.38 (cathepsin K) inhibitor | CHEBI_64406 | |
| fluorescent probe | CHEBI_39442 | |
| Langerhans-cell histiocytosis | DOID_2571 | [A histiocytosis that is characterized by clonal proliferation of Langerhans cells.] |
| EC 3.2.1.18 (exo-alpha-sialidase) inhibitor | CHEBI_52425 | |
| HIV-1 reverse transcriptase inhibitor | CHEBI_53756 | |
| differentiation agent | BAO_0002087 | [The molecular entity that brings about the transformation of less specialized cells to more specialized cell types, which differ morphologically and /or functionally.] |
| activator | BAO_0002088 | [The role of a molecular entity to bring about an increase of a predefined stimulus in an assay. ] |
| barbiturate dependence | DOID_2575 | [A drug dependence that involves the continued use of barbiturates despite problems related to use of the substance.] |
| inactive | PATO_0002355 | [A quality of a physical object that is currently realizing none of its functions.] |
| active | PATO_0002354 | [A quality of an physical object that is currently realizing one of its functions.] |